SecBot SecBot
SECBOTREPLAY Home › Report › TRVI

TRVI · Trevi Therapeutics is holding its 2026 annual meeting where…

Trevi Therapeutics, Inc. · DEFA14A filed Apr 21, 2026 at 16:00 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Apr 21, 2026 at 16:00 ET

Trevi Therapeutics is holding its 2026 annual meeting where shareholders will vote on several proposals including electing a director, ratifying auditors, approving executive compensation, amending the stock incentive plan, and increasing authorized shares. This is a routine annual shareholder meeting.

  • Annual meeting to vote on director election, auditor ratification, executive compensation, stock incentive plan amendment, and share authorization
  • Board recommends voting for all proposals
  • Meeting date: June 3, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access